Sanofi has announced Phase 2 trial results for Lunsekimig, a bispecific biologic targeting two well-known drivers of inflammation: TSLP and... Read more
Category: Uncategorized
Gilead Sciences acquires biotech firm Tubulis in a deal worth up to $5 billion
Gilead Sciences has announced an agreement to acquire Tubulis, a German biotechnology startup, in a transaction valued at potentially $5... Read more
Neurocrine Biosciences executes historic $2.9B acquisition of Soleno Therapeutics
Defying its long-standing reputation as a potential takeover target, Neurocrine Biosciences has taken a decisive step by acquiring Soleno Therapeutics... Read more
Vertex pays $15M to leverage Halozyme’s high-concentration drug delivery tech
In a strategic move to enhance patient convenience and treatment adherence, Vertex Pharmaceuticals has entered into a licensing agreement to... Read more
Merck and Zhifei restructure vaccine distribution pact in China
Following a sharp decline in demand for the HPV vaccine (Gardasil) in China, Merck & Co. and its domestic distribution... Read more
Pharmedic faces financial hurdles and quality issues in early 2026
Pharmedic Pharmaceutical Medicinal Joint Stock Company (Ticker: PMC), traditionally known for its stable cash flow in the Southern market, is... Read more
Danang Pharma shifts focus toward profit-driven growth and restructuring
At its Annual General Meeting in early April 2026, Danang Pharmaceutical - Medical Equipment JSC (Ticker: DDN) approved a new... Read more
Domestic medical enterprises petition against “double barriers” in procurement tenders
Local medical equipment manufacturers have collectively submitted petitions to regulatory bodies and major hospitals, highlighting technical barriers that disadvantage domestic... Read more
Vietnam engages in dialogue with 13 nations on food safety policy reforms
On April 7, the Ministry of Health held a working session with representatives from 13 embassies and international delegations (including... Read more









